Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03108846 · ClinicalTrials.gov registry record · Phase 3

Escitalopram for Agitation in Alzheimer's Disease

A Phase 3 study of Dementia, sponsored by JHSPH Center for Clinical Trials.

Active
Registry status
Phase 3
Development phase
187
Enrollment target
20
Study locations

NCT03108846 is a Phase 3 study of Dementia that is active but no longer recruiting, run by JHSPH Center for Clinical Trials. The registered enrollment target is 187 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03108846, a Phase 3 study of Dementia, is active but no longer recruiting, sponsored by JHSPH Center for Clinical Trials.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
187 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.

Conditions Studied

Dementia

Interventions

  • DRUG Placebo
  • DRUG Escitalopram

Study Locations (20)

Arkansas

  • Biomedical Research Foundation - Little Rock
  • University of Arkansas for Medical Sciences - Little Rock

California

  • University of California Los Angeles/VA Greater Los Angeles Healthcare System - Los Angeles
  • University of Southern California Keck School of Medicine Memory and Aging Center - Los Angeles

Maryland

  • Maryland VA Health Care System - Baltimore
  • Johns Hopkins University School of Medicine, Bayview Medical Center - Baltimore

New York

  • Columbia University - New York
  • University of Rochester Medical Center - Rochester

Pennsylvania

  • Abington Neurological Associates, Ltd - Abington
  • Alzheimer Disease Research Center; University of Pittsburgh - Pittsburgh

Texas

  • Baylor AT&T Memory Center - Dallas
  • UT Health San Antonio - San Antonio

Arizona

  • Banner Sun Health Research Institute - Sun City

Florida

  • Miami Jewish Health Systems - Miami

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2018-01-03
Est. Completion 2025-05
Phase Phase 3

Sponsor

JHSPH Center for Clinical Trials

12 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03108846

The ClinicalTrials.gov registry entry for NCT03108846 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The listed sponsor is JHSPH Center for Clinical Trials, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03108846 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Arkansas, California, Maryland.

Frequently Asked Questions

What is clinical trial NCT03108846 about?

NCT03108846 is a clinical study titled "Escitalopram for Agitation in Alzheimer's Disease". The purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.

What is the current status of trial NCT03108846?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 187 participants. The study started on 2018-01-03. Estimated completion is 2025-05.

What conditions does trial NCT03108846 study?

This clinical trial studies the following conditions: Dementia.

What interventions are being tested in trial NCT03108846?

The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG).

Who is sponsoring clinical trial NCT03108846?

This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03108846 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dementia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.